Yutaka Ohsawa Selected Research

Yutaka Ohsawa Research Topics

Disease

8	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 11/2022 - 01/2004
6	Muscular Atrophy (Muscle Atrophy) 01/2023 - 11/2006
5	Type 1C Limb-Girdle Muscular Dystrophy 11/2022 - 01/2004
4	Muscular Dystrophies (Muscular Dystrophy) 10/2017 - 08/2006
2	Hypertrophy 11/2022 - 01/2013
2	Stroke (Strokes) 01/2019 - 01/2012
2	MELAS Syndrome (Syndrome, MELAS) 01/2019 - 01/2012
2	Alzheimer Disease (Alzheimer's Disease) 12/2017 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2017 - 10/2016
2	Polyneuropathies (Polyneuropathy) 10/2017 - 05/2008
1	Muscle Weakness 05/2023
1	Sarcopenia 01/2023
1	Glycogen Storage Disease Type Ix 04/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Amyloidosis 10/2017
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 10/2017
1	Sarcoglycanopathies 10/2017
1	Tauopathies 10/2016
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2016
1	Dementia (Dementias) 10/2016
1	Atrophy 10/2016
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2015
1	Herpes Zoster 11/2013
1	Chronic Renal Insufficiency 11/2013
1	Juvenile gout 11/2013
1	Hyperuricemia 11/2013
1	Neoplasms (Cancer) 08/2012
1	Brain Diseases (Brain Disorder) 01/2012
1	Lactic Acidosis 01/2012
1	Muscular Diseases (Myopathy) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Obesity 03/2011
1	Miyoshi myopathy 01/2010
1	Dysferlinopathy 01/2010
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2004
1	Periodontitis 05/2002

Drug/Important Bio-Agent (IBA)

6	Caveolin 3IBA 11/2022 - 01/2004
6	MyostatinIBA 02/2015 - 11/2006
3	CaveolinsIBA 11/2022 - 08/2012
2	Ki26894IBA 01/2023 - 08/2012
2	NucleotidesIBA 01/2019 - 01/2012
2	AnticodonIBA 01/2019 - 01/2012
2	Taurine FDA Link 01/2019 - 01/2012
2	Leu Transfer RNAIBA 01/2019 - 01/2012
2	Culture MediaIBA 12/2017 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 01/2015
2	Peptides (Polypeptides)IBA 02/2015 - 03/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2015 - 05/2008
2	atelocollagenIBA 01/2013 - 01/2011
2	Small Interfering RNA (siRNA)IBA 01/2013 - 01/2011
1	GlucocorticoidsIBA 05/2023
1	Methotrexate (Mexate)FDA LinkGeneric 05/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 05/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA 04/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Codon (Codons)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Prealbumin (Transthyretin)IBA 10/2017
1	Sarcoglycans (beta Sarcoglycan)IBA 10/2017
1	Dystroglycans (Dystroglycan)IBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	CalciumIBA 10/2016
1	Cysteine (L-Cysteine)FDA Link 11/2013
1	CreatinineIBA 11/2013
1	Epidermal Growth Factor (EGF)IBA 11/2013
1	Uric Acid (Urate)IBA 11/2013
1	UromodulinIBA 11/2013
1	Therapeutic UsesIBA 01/2013
1	Phosphotransferases (Kinase)IBA 08/2012
1	Transforming Growth Factor-beta Type I ReceptorIBA 08/2012
1	FollistatinIBA 03/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 03/2011
1	DysferlinIBA 01/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2002
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2002
1	Interferon-gamma (Interferon, gamma)IBA 05/2002
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 05/2002
1	CytokinesIBA 05/2002

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2006
3	Oral Administration 01/2023 - 01/2012
1	Intramuscular Injections 01/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2006